Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19. Yan VC. Clin Infect Dis 2022 Nov 8. pii: 6809131. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan VC. Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19. Clin Infect Dis 2022 Nov 8. pii: 6809131. doi: 10.1093.
PMID: 36346111